Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Research for Individualized Therapeutics in Rare Genetic Disease

NCT05236595 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05236595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05236595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Research for Individualized Therapeutics in Rare Genetic Disease
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Enrolling by invitation
Start date
November 24, 2021
Completion date
November 30, 2026
Enrollment
50 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

rare genetic disease, undiagnosed diseases